ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 86 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $215,286 | -6.3% | 145,473 | +1.9% | 0.00% | – |
Q2 2023 | $229,864 | +53732.3% | 142,773 | -3.1% | 0.00% | -100.0% |
Q1 2023 | $427 | -9.0% | 147,372 | +3.0% | 0.00% | 0.0% |
Q4 2022 | $469 | -99.9% | 143,057 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $536,000 | -50.6% | 141,705 | +1.8% | 0.00% | -50.0% |
Q2 2022 | $1,084,000 | -2.3% | 139,185 | +16.6% | 0.00% | +100.0% |
Q1 2022 | $1,109,000 | -45.1% | 119,354 | -6.8% | 0.00% | -50.0% |
Q4 2021 | $2,019,000 | -10.5% | 128,089 | +1.6% | 0.00% | -33.3% |
Q3 2021 | $2,256,000 | +14.2% | 126,037 | -0.8% | 0.00% | 0.0% |
Q2 2021 | $1,975,000 | +18.4% | 127,034 | +9.4% | 0.00% | +50.0% |
Q1 2021 | $1,668,000 | -30.7% | 116,133 | -5.2% | 0.00% | -33.3% |
Q4 2020 | $2,406,000 | +73.2% | 122,545 | +14.4% | 0.00% | +50.0% |
Q3 2020 | $1,389,000 | -10.2% | 107,164 | +1.0% | 0.00% | -33.3% |
Q2 2020 | $1,546,000 | +146.2% | 106,115 | +43.9% | 0.00% | +200.0% |
Q1 2020 | $628,000 | -45.3% | 73,762 | +5.8% | 0.00% | -50.0% |
Q4 2019 | $1,148,000 | +19.5% | 69,716 | +2.4% | 0.00% | 0.0% |
Q3 2019 | $961,000 | -22.6% | 68,067 | +10.3% | 0.00% | 0.0% |
Q2 2019 | $1,241,000 | -43.4% | 61,735 | +11.8% | 0.00% | -50.0% |
Q1 2019 | $2,194,000 | +12.2% | 55,195 | -2.0% | 0.00% | 0.0% |
Q4 2018 | $1,956,000 | +27.0% | 56,305 | +51.2% | 0.00% | +33.3% |
Q3 2018 | $1,540,000 | +6.8% | 37,243 | -5.1% | 0.00% | 0.0% |
Q2 2018 | $1,442,000 | +10.2% | 39,238 | +16.9% | 0.00% | 0.0% |
Q1 2018 | $1,309,000 | +166.1% | 33,565 | +23.4% | 0.00% | +200.0% |
Q4 2017 | $492,000 | -5.9% | 27,202 | -13.9% | 0.00% | 0.0% |
Q3 2017 | $523,000 | +19.1% | 31,598 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $439,000 | -24.2% | 31,373 | +11.3% | 0.00% | 0.0% |
Q1 2017 | $579,000 | +49.2% | 28,198 | +3.1% | 0.00% | 0.0% |
Q4 2016 | $388,000 | -34.5% | 27,350 | -1.1% | 0.00% | -50.0% |
Q3 2016 | $592,000 | -1.3% | 27,655 | +3.8% | 0.00% | 0.0% |
Q2 2016 | $600,000 | +82.4% | 26,645 | +53.9% | 0.00% | +100.0% |
Q1 2016 | $329,000 | -28.3% | 17,310 | -0.3% | 0.00% | 0.0% |
Q4 2015 | $459,000 | +4.1% | 17,370 | +23.9% | 0.00% | -50.0% |
Q3 2015 | $441,000 | -32.6% | 14,025 | +13.1% | 0.00% | 0.0% |
Q2 2015 | $654,000 | – | 12,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
Baupost Group | 9,773,616 | $15,736 | 0.28% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
XTX Topco Ltd | 136,841 | $220,314 | 0.04% |